All Infectious Disease articles – Page 18
-
NewsHospital bug jumps from lungs to gut, raising sepsis risk
A hospital-acquired bacterium that causes serious infections can move from the lungs to the gut inside the same patient, raising the risk of life-threatening sepsis, new research reveals.
-
NewsEmerging human and canine leptospirosis in New South Wales shows separate transmission pathways
A geospatial study of leptospirosis outbreaks in New South Wales suggests that humans and dogs may have largely independent transmission pathways.
-
NewsNew collection of bacteria-eating viruses can tackle hospital superbug
An international team of researchers have comprehensively catalogued a new collection of bacteria-eating viruses called phages sourced, in part, from hospital wastewater. The phages have been shown to be effective against different strains of Klebsiella pneumoniae.
-
News‘FluWarning’ system raises early alerts for virus spillovers
How can we monitor the cross-species transmission of avian flu? The answer is FluWarning, a digital system that reports abnormal changes in flu viruses. It analyses their genetic code, looking for subtle but significant changes that could indicate cross-species transmission.
-
NewsNew vaccine against a deadly virus acts fast and protects for over a year
A research team has developed a vaccine made from a non-infectious version of the Crimean-Congo hemorrhagic fever virus that protects quickly and provides long-lasting immunity.
-
NewsNew flu strain underscores urgent need for vigilance, vaccination, and investment in virus science
Virologists have issued a statement on the emergence of a new influenza A (H3N2) variant known as H3N2 subclade K that is spreading rapidly and may contribute to a more intense flu season worldwide. Public health agencies have reported sharp week-over-week increases in cases driven by this subclade.
-
NewsScientists uncover how COVID-19 variants outsmart the immune system
Researchers have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes COVID-19, and how viral mutations weaken that attachment.
-
NewsGlobal Virus Network awards pandemic preparedness grants to advance global surveillance and early detection of viral threats
The Global Virus Network (GVN) is awarding pandemic preparedness research grants, totaling $160,000, to scientists across four continents, supporting innovative, investigator-led projects designed to enhance viral surveillance, early detection, and scientific preparedness.
-
NewsNew research confirms HPV vaccination prevents cervical cancer
Two new Cochrane reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus.
-
NewsToxic gut bacteria may drive ulcerative colitis by killing protective immune cells
A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal homeostasis, according to a new study. The findings suggest potential for new treatment strategies.
-
NewsRebalancing lung repair with immune damage is key to surviving severe influenza
Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus, according to a new study in mice, which shows that pairing modest antiviral therapies with immune modulation can restore damaged tissues and lung function, even after severe infection has taken hold.
-
NewsMaternal health programme cuts infection deaths by 32%
A landmark multi-country clinical trial has shown that a structured, sustainable approach to infection prevention and treatment can save women’s lives, cutting severe maternal infections and deaths by about one-third (32%) compared to usual care.
-
NewsResearchers diagnose disease with a drop of blood, a microscope and AI
Scientists have developed an automated, high-throughput system that relies on imaging droplets of biofluids for disease diagnosis in an attempt to reduce the number of consumables and equipment needed for biomedical testing.
-
NewsScientists use computer model to improve hospitals’ ability to limit spread of drug-resistant infections
The computer model improves on traditional methods like contact tracing by inferring asymptomatic carriers in the spread of antibiotic-resistant infections.
-
NewsStudy unveils structure, identification and characterization of the RibD-enolase complex in Francisella
A study aiming to identify anti-tularemia drug targets determined the atomic structure and identified its components of the native RibD-enolase protein complex in Francisella novicida.
-
NewsNew nanogel technology destroys drug-resistant bacteria in hours
A novel technology shows over 99.9% effectiveness against Pseudomonas aeruginosa (P. aeruginosa). It centres on a heteromultivalent nanogel: a flexible particle made by crosslinking polymers and adding sugar residues (galactose and fucose) alongside antimicrobial peptides.
-
NewsGSK and Fleming Initiative scientists unite to target AMR with advanced AI
GSK and the Fleming Initiative have announced six major new research programmes, called ‘Grand Challenges’ which harness some of the best scientific expertise and the latest technologies, including advanced AI, to find new ways to slow the progress of antimicrobial resistance (AMR).
-
NewsScripps Research scientists receive $1.1 million to advance AI modeling for HIV vaccine development
Scripps Research scientists will purchase high-performance computing equipment to accelerate the identification of more effective HIV vaccine candidates through enhanced computational infrastructure, reduced data-processing bottlenecks, and state-of-the-art artificial intelligence (AI) technology.
-
News$3.7 million awarded for research into sand flies, vectors of parasitic disease leishmaniasis
Professor Gideon Wasserberg at UNC Greensboro has been awarded a prestigious $3.7 million National Institutes of Health R01 grant to advance his research on controlling sand flies, the vectors of the parasitic disease leishmaniasis.
-
NewsPhase 2 clinical trial results show potential to shorten TB treatment time
New clinical trial results show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, has the potential to improve tuberculosis (TB) treatment when combined with pretomanid and linezolid in a treatment regimen known as “SPaL.”